CD14 and rheumatoid arthritis: Thus, to adequately characterize the molecular profile of distinct monocyte subsets involved in CVD in the setting of RA, we developed transcriptomic and intracellular signaling comparative studies between the global CD16+ monocytes population and the classical CD14+ monocytes subsets.